Search clinical trials for: Androgen Pathway Modulation-Resistant

Total 3812 results

Washington University School of Medicine
ImmunityBio, Inc.; Dendreon

Not yet recruiting

Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer

United States
Novartis Pharmaceuticals

Recruiting

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

Prostatic Neoplasms, Castration-Resistant

United States
Prostate Cancer Clinical Trials Consortium
Pfizer; Dana-Farber Cancer Institute; Fred Hutchinson Cancer Center

Not yet recruiting

A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy (MOMENT)

Prostate Cancer (Adenocarcinoma) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals

Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Australia, United States, Canada, South Korea, Japan
Bayer

Recruiting

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics (Double-DARE)

Prostatic Neoplasms | Metastatic Hormone-Sensitive Prostate Cancer

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe